Zhu et al. (51) studied the regulatory mechanism of SNHG12 in conferring multidrug resistance (MDR) to Natural Killer/T-cell lymphoma (NKTCL). This evidence concerns the gene SNHG12 and extranodal nasal NK/T cell lymphoma.